Scott Praill's most recent trade in TuHURA Biosciences Inc. was a trade of 720,260 Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 720,260 | 720,260 | - | - | Option (right to buy) | |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 240,087 | 277,273 (2%) | 2% | 0 | Common Stock | |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 08 Dec 2021 | 28,700 | 37,186 (0%) | 0% | 0.7 | 19,430 | Common Stock |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | 29 Apr 2021 | 3,750 | 0 | - | - | Series B Convertible Preferred Stock | ||
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | 29 Apr 2021 | 938 | 8,486 (0%) | 0% | - | Common Stock | ||
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 29 Apr 2021 | 8 | 7,548 (0%) | 0% | 0 | Common Stock | |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Mar 2021 | 22 | 7,540 (0%) | 0% | 0 | Common Stock | |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 30 Sep 2020 | 22 | 7,496 (0%) | 0% | 0 | Common Stock | |
TuHURA Biosciences Inc. | Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 606,557 | 606,557 | - | - | Options (Right to Buy) |